The antiserum was produced against synthesized peptide derived from human TAK1 around the phosphorylation site of Thr184. AA range:161-210

Phospho-Tak1 (T184) Polyclonal Antibody detects endogenous levels of Tak1 protein only when phosphorylated at T184.The name of modified sites may be influenced by many factors, such as species (the modified site was not originally found in human samples) and the change of protein sequence (the previous protein sequence is incomplete, and the protein sequence may be prolonged with the development of protein sequencing technology). When naming, we will use the "numbers" in historical reference to keep the sites consistent with the reports. The antibody binds to the following modification sequence (lowercase letters are modification sites):IQtHM

MAP3K7

Mitogen-activated protein kinase kinase kinase 7

MAP3K7 ;
TAK1 ;
Mitogen-activated protein kinase kinase kinase 7 ;
Transforming growth factor-beta-activated kinase 1 ;
TGF-beta-activated kinase 1

The protein encoded by this gene is a member of the serine/threonine protein kinase family. This kinase mediates the signaling transduction induced by TGF beta and morphogenetic protein (BMP) , and controls a variety of cell functions including transcription regulation and apoptosis. In response to IL-1 , this protein forms a kinase complex including TRAF6 , MAP3K7P1/TAB1 and MAP3K7P2/TAB2; this complex is required for the activation of nuclear factor kappa B. This kinase can also activate MAPK8/JNK , MAP2K4/MKK4 , and thus plays a role in the cell response to environmental stresses. Four alternatively spliced transcript variants encoding distinct isoforms have been reported. [provided by RefSeq , Jul 2008] ,

Catalytic activity:ATP + a protein = ADP + a phosphoprotein. ,cofactor:Magnesium. ,Function:Component of a protein kinase signal transduction cascade. Mediator of TGF-beta signal transduction. Stimulates NF-kappa-B activation and the p38 MAPK pathway. ,PTM:Association with MAP3K7IP1 promotes autophosphorylation and subsequent activation. Dephosphorylation at Thr-187 by PP2A and PPP6C leads to inactivation. ,similarity:Belongs to the protein kinase superfamily. ,similarity:Belongs to the protein kinase superfamily. STE Ser/Thr protein kinase family. MAP kinase kinase kinase subfamily. ,similarity:Contains 1 protein kinase domain. ,subunit:Binds both upstream activators and downstream substrates in multimolecular complexes. Interacts with MAP3K7IP1 and MAP3K7IP2. Interacts with PPM1L. Interaction with PP2A and PPP6C leads to its' repressed activity. ,

Cytoplasm . Cell membrane ; Peripheral membrane protein ; Cytoplasmic side . Although the majority of MAP3K7/TAK1 is found in the cytosol , when complexed with TAB1/MAP3K7IP1 and TAB2/MAP3K7IP2 , it is also localized at the cell membrane.

>>MAPK signaling pathway ;
>>NF-kappa B signaling pathway ;
>>Autophagy - animal ;
>>AMPK signaling pathway ;
>>Wnt signaling pathway ;
>>Osteoclast differentiation ;
>>Adherens junction ;
>>Neutrophil extracellular trap formation ;
>>Toll-like receptor signaling pathway ;
>>NOD-like receptor signaling pathway ;
>>RIG-I-like receptor signaling pathway ;
>>IL-17 signaling pathway ;
>>T cell receptor signaling pathway ;
>>TNF signaling pathway ;
>>Alcoholic liver disease ;
>>Pathogenic Escherichia coli infection ;
>>Shigellosis ;
>>Salmonella infection ;
>>Yersinia infection ;
>>Leishmaniasis ;
>>Toxoplasmosis ;
>>Hepatitis B ;
>>Measles ;
>>Herpes simplex virus 1 infection ;
>>Epstein-Barr virus infection ;
>>Human immunodeficiency virus 1 infection ;
>>Coronavirus disease - COVID-19 ;
>>Lipid and atherosclerosis ;
>>Fluid shear stress and atherosclerosis